WGCNA-based Identification of Potential Targets and Pathways in Response to Treatment in Locally Advanced Breast Cancer Patients

Overview

Journal Open Med (Wars)

Specialty General Medicine

Date 2023 Mar 10

PMID 36896338

Authors

Ruipeng Zhao

Wan Wei

Linlin Zhen

Affiliations

Soon will be listed here.

Abstract

Locally advanced breast cancer patients have a poor prognosis; however, the relationship between potential targets and the response to treatment is still unclear. The gene expression profiles of breast cancer patients with stages from IIB to IIIC were downloaded from The Cancer Genome Atlas. We applied weighted gene co-expression network analysis and differentially expressed gene analysis to identify the primary genes involved in treatment response. The disease-free survival between low- and high-expression groups was analyzed using Kaplan-Meier analysis. Gene set enrichment analysis was applied to identify hub genes-related pathways. Additionally, the CIBERSORT algorithm was employed to evaluate the correlation between the hub gene expression and immune cell types. A total of 16 genes were identified to be related to radiotherapy response, and low expression of SVOPL, EDAR, GSTA1, and ABCA13 was associated with poor overall survival and progression-free survival in breast cancer cases. Correlation analysis revealed that the four genes negatively related to some specific immune cell types. The four genes were downregulated in H group compared with the L group. Four hub genes associated with the immune cell infiltration of breast cancer were identified; these genes might be used as a promising biomarker to test the treatment in breast cancer patients.

Citing Articles

Weighted gene co-expression network analysis reveals key stromal prognostic markers in pancreatic cancer.

Mantini G, Agostini A, Tufo M, Rossi S, Kulesko M, Carbone C Sci Rep. 2024; 14(1):31749.

PMID: 39738404 PMC: 11685961. DOI: 10.1038/s41598-024-82563-9.

Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement.

Suman M, Lofgren M, Fransson S, Yousuf J, Svensson J, Djos A J Transl Med. 2024; 22(1):808.

PMID: 39217334 PMC: 11366169. DOI: 10.1186/s12967-024-05634-5.

Identification of shared disease marker genes and underlying mechanisms between rheumatoid arthritis and Crohn disease through bioinformatics analysis.

Peng P, Shen Y Medicine (Baltimore). 2024; 103(26):e38690.

PMID: 38941374 PMC: 11466148. DOI: 10.1097/MD.0000000000038690.

The potential mechanism of HIF-1α and CD147 in the development of triple-negative breast cancer.

Chen M, Liu Z, Zheng K, Hu C, Peng P Medicine (Baltimore). 2024; 103(23):e38434.

PMID: 38847725 PMC: 11155533. DOI: 10.1097/MD.0000000000038434.

Transcriptome analysis revealed SMURF2 as a prognostic biomarker for oral cancer.

Deng L, Wu Z, Sun C, Liu Z J Appl Genet. 2024; 66(1):155-170.

PMID: 38698292 PMC: 11762210. DOI: 10.1007/s13353-024-00869-w.

References

Speers C, Zhao S, Liu M, Bartelink H, Pierce L, Feng F . Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer. Clin Cancer Res. 2015; 21(16):3667-77. DOI: 10.1158/1078-0432.CCR-14-2898. View

Liu W, Li L, Ye H, Tu W . [Weighted gene co-expression network analysis in biomedicine research]. Sheng Wu Gong Cheng Xue Bao. 2017; 33(11):1791-1801. DOI: 10.13345/j.cjb.170006. View

Qi X, Pajonk F, McCloskey S, Low D, Kupelian P, Steinberg M . Radioresistance of the breast tumor is highly correlated to its level of cancer stem cell and its clinical implication for breast irradiation. Radiother Oncol. 2017; 124(3):455-461. PMC: 6128144. DOI: 10.1016/j.radonc.2017.08.019. View

Snow H, Mitchell C, Hendry S, McKinley M, Byrne D, Ngan S . Characterising the immune microenvironment in liposarcoma, its impact on prognosis and the impact of radiotherapy. J Surg Oncol. 2020; 123(1):117-126. DOI: 10.1002/jso.26261. View

Takano S, Omura M, Suzuki R, Tayama Y, Matsui K, Hashimoto H . Intensity-modulated radiation therapy using TomoDirect for postoperative radiation of left-sided breast cancer including lymph node area: comparison with TomoHelical and three-dimensional conformal radiation therapy. J Radiat Res. 2019; 60(5):694-704. PMC: 6805983. DOI: 10.1093/jrr/rrz052. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

Hlavac V, Brynychova V, Vaclavikova R, Ehrlichova M, Vrana D, Pecha V . The expression profile of ATP-binding cassette transporter genes in breast carcinoma. Pharmacogenomics. 2013; 14(5):515-29. DOI: 10.2217/pgs.13.26. View

Munir M, Kay M, Kang M, Rahman M, Al-Harrasi A, Choudhury M . Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth. Int J Mol Sci. 2021; 22(12). PMC: 8233875. DOI: 10.3390/ijms22126526. View

Garaud S, Buisseret L, Solinas C, Gu-Trantien C, De Wind A, Van den Eynden G . Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer. JCI Insight. 2019; 5. PMC: 6795287. DOI: 10.1172/jci.insight.129641. View

10.

Trivedi S, Choudhary P, Lo Q, Sritharan H, Iyer A, Batumalai V . Persistent reduction in global longitudinal strain in the longer term after radiation therapy in patients with breast cancer. Radiother Oncol. 2018; 132:148-154. DOI: 10.1016/j.radonc.2018.10.023. View

11.

Jiang W, Chan C, Weissman I, Kim B, Hahn S . Immune Priming of the Tumor Microenvironment by Radiation. Trends Cancer. 2017; 2(11):638-645. DOI: 10.1016/j.trecan.2016.09.007. View

12.

Langfelder P, Horvath S . WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008; 9:559. PMC: 2631488. DOI: 10.1186/1471-2105-9-559. View

13.

Portella L, Scala S . Ionizing radiation effects on the tumor microenvironment. Semin Oncol. 2019; 46(3):254-260. DOI: 10.1053/j.seminoncol.2019.07.003. View

14.

Tian Y, Yan M, Zheng J, Li R, Lin J, Xu A . miR-483-5p decreases the radiosensitivity of nasopharyngeal carcinoma cells by targeting DAPK1. Lab Invest. 2019; 99(5):602-611. DOI: 10.1038/s41374-018-0169-6. View

15.

De Ruysscher D, Niedermann G, Burnet N, Siva S, Lee A, Hegi-Johnson F . Radiotherapy toxicity. Nat Rev Dis Primers. 2019; 5(1):13. DOI: 10.1038/s41572-019-0064-5. View

16.

Santivasi W, Xia F . Ionizing radiation-induced DNA damage, response, and repair. Antioxid Redox Signal. 2013; 21(2):251-9. DOI: 10.1089/ars.2013.5668. View

17.

Ahn J, Gammon M, Santella R, Gaudet M, Britton J, Teitelbaum S . Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis. 2006; 27(9):1876-82. DOI: 10.1093/carcin/bgl038. View

18.

Boot A, Oosting J, Doorn S, Ouahoud S, Ventayol Garcia M, Ruano D . Allelic Switching of , , and during Colorectal Cancer Tumorigenesis. Int J Genomics. 2019; 2019:1287671. PMC: 6481143. DOI: 10.1155/2019/1287671. View

19.

Terrazzino S, La Mattina P, Gambaro G, Masini L, Franco P, Canonico P . Common variants of GSTP1, GSTA1, and TGFβ1 are associated with the risk of radiation-induced fibrosis in breast cancer patients. Int J Radiat Oncol Biol Phys. 2011; 83(2):504-11. DOI: 10.1016/j.ijrobp.2011.06.2012. View

20.

Hollern D, Xu N, Thennavan A, Glodowski C, Garcia-Recio S, Mott K . B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer. Cell. 2019; 179(5):1191-1206.e21. PMC: 6911685. DOI: 10.1016/j.cell.2019.10.028. View